NKARTA INC's ticker is NKTX and the CUSIP is 65487U108. A total of 90 filers reported holding NKARTA INC in Q2 2021. The put-call ratio across all filers is 5.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,960,606 | -36.5% | 3,568,781 | 0.0% | 0.38% | -35.8% |
| Q2 2023 | $7,815,630 | -38.3% | 3,568,781 | 0.0% | 0.60% | -31.8% |
| Q1 2023 | $12,669,173 | -40.7% | 3,568,781 | 0.0% | 0.88% | -27.1% |
| Q4 2022 | $21,376,998 | -54.5% | 3,568,781 | -0.1% | 1.20% | -48.8% |
| Q3 2022 | $47,003,000 | +6.8% | 3,571,640 | 0.0% | 2.35% | +3.8% |
| Q2 2022 | $44,003,000 | +33.1% | 3,571,640 | +22.9% | 2.26% | +136.6% |
| Q1 2022 | $33,059,000 | -25.9% | 2,904,974 | 0.0% | 0.96% | +6.0% |
| Q4 2021 | $44,591,000 | -44.8% | 2,904,974 | 0.0% | 0.90% | -6.1% |
| Q3 2021 | $80,787,000 | -12.2% | 2,904,974 | 0.0% | 0.96% | -19.9% |
| Q2 2021 | $92,059,000 | -3.7% | 2,904,974 | 0.0% | 1.20% | -44.1% |
| Q1 2021 | $95,574,000 | -46.5% | 2,904,974 | 0.0% | 2.14% | -54.5% |
| Q4 2020 | $178,569,000 | +104.5% | 2,904,974 | 0.0% | 4.72% | +27.5% |
| Q3 2020 | $87,324,000 | – | 2,904,974 | – | 3.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,702 | $23,155,000 | 5.83% |
| Novo Holdings A/S | 2,793,863 | $31,794,000 | 1.68% |
| Deep Track Capital, LP | 2,113,795 | $24,055,000 | 1.54% |
| RA Capital Management | 5,605,129 | $63,786,000 | 1.39% |
| NEA Management Company, LLC | 2,904,974 | $33,059,000 | 0.96% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $2,276,000 | 0.46% |
| Vivo Capital, LLC | 512,225 | $5,829,000 | 0.40% |
| Rock Springs Capital Management LP | 509,948 | $5,803,000 | 0.15% |
| Virtus ETF Advisers LLC | 12,126 | $138,000 | 0.06% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 10,034 | $209,000 | 0.05% |